Researchers have developed staged prediction models to assess perioperative virological suppression and prognostic factors in patients with hepatitis B virus-related hepatocellular carcinoma receiving urgent antiviral therapy.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.